Significance of the High-risk Hpv Viral Load

Status Completed

Clinical Trial Summary

The aim of this study is to evaluate the significance of an elevated high-risk HPV (HR-HPV) viral load.

Clinical Trial Description

We will particularly evaluate if the HR-HPV viral load: - Is correlated to the transcription of the genes of the oncoproteins E6 and E7 - Is predictive of the integration of the virus in infected cells - Is predictive of the presence of HPV in patients' blood - Influences the local and systemic immunologic response ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00682812
Study type	Interventional
Source	Assistance Publique Hopitaux De Marseille
Contact
Status	Completed
Phase	N/A
Start date	June 16, 2008
Completion date	May 23, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00956553` - Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls	Phase 4
Completed	`NCT05372016` - Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	Phase 3
Recruiting	`NCT05027776` - Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years	Phase 3
Suspended	`NCT00733122` - Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)	Phase 3
Recruiting	`NCT04895020` - Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years	Phase 3
Recruiting	`NCT05371353` - Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Completed	`NCT03900572` - A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine	Phase 1
Completed	`NCT00635830` - An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)	Phase 1
Not yet recruiting	`NCT01021904` - Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China	Phase 4
Completed	`NCT00378560` - V501 Efficacy Study in Women Aged 18 to 26 (V501-027)	Phase 2
Completed	`NCT01086709` - Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Completed	`NCT00711815` - A Study to Identify Markers in Blood and Tissue of HPV Clearance	N/A
Completed	`NCT00834106` - Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)	Phase 3
Completed	`NCT03085381` - A Phase I Study of Quadrivalent HPV Recombinant Vaccine	Phase 1
Completed	`NCT00847340` - Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population	N/A
Completed	`NCT00411749` - V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)	Phase 2
Completed	`NCT00943722` - A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)	Phase 3